tirzepatide surmount-1 trial weight loss non-diabetic SURMOUNT-1: Drastically Reduces in Obese Patients SURMOUNT 1 // Three-Year Obesty

In a rat model of diabetic depression-like behavior, the combination of BBR and ginsenoside (Rb1) improves glucose metabolism and IR, increases the expression of brain-derived neurotrophic factor protein, and relieves depression-like behavior in rats

Box indicates seven bottles per box

Researchers tested the triple-dose of semaglutide in two clinical trials, one involving people with obesity and the other in people with obesity and type 2 diabetes

Future studies leveraging the genetic tractability of Drosophila could further dissect the molecular pathways influenced by such natural compounds, accelerating the discovery of novel AD therapeutics